Network meta-analysis of Chinese herb injections combined with FOLFOX chemotherapy in the treatment of advanced colorectal cancer.

CONCLUSIONS: Most of the included studies were of low quality, and there was a scarcity of eligible trials and numbers of participants. Based on currently limited evidence, aidi, shenqifuzheng and compound matrine were superior to other CHIs in patients receiving FOLFOX chemotherapy for advanced CRC. More studies are required to confirm the efficacy of CHIs in combination with FOLFOX for advanced CRC.
PMID: 27338003 [PubMed - in process]

Source: Clinical Colorectal Cancer - June 26, 2016 Category: Cancer & Oncology Authors: Ge L, Wang YF, Tian JH, Mao L, Zhang J, Zhang JH, Shen XP, Yang KH Tags: J Clin Pharm Ther Source Type: research